Trial
NCT07020832
Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Phase IIISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Apellis Pharmaceuticals, Inc.
Collaborators
—
Condition
Delayed Graft Function
Intervention
Pegcetacoplan
Why stopped
Study temporarily suspended due to company acquisition and ongoing strategic evaluation of the program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-18